Notably, 5-HT3R antagonists have been proposed as promising treatments across psychiatric conditions, including schizophrenia, due to their favorable side effect profiles, potential to improve negative symptoms, and procognitive effects [401]. Here, HTR3A is linked to schizophrenia.